Healthstream price to free cash flow HSTM
Market value divided by free cash flow over the last twelve months, since 2012.
- Today, Oct 23, 2026
- 14.7×
- 10-year median
- 17.0×
- Against its 10-year history
- 29th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 9.8× to 96.2×
- Peer median
- 6.5×
Healthstream's price to free cash flow is 14.7× as of Oct 23, 2026.
That is below its ten-year median of 17.0×, lower than on 71% of days in the last ten years.
Over that time it ranged from 9.8× in Apr 2026 to 96.2× in Oct 2016.
The median for 10 application software stocks of a similar size is 6.5×.
Price to free cash flow over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 14.7× | 9.8× | 14.7× |
| 2025 | 12.2× | 12.2× | 18.4× |
| 2024 | 16.4× | 12.1× | 17.1× |
| 2023 | 14.6× | 13.3× | 17.0× |
| 2022 | 16.3× | 13.9× | 20.9× |
| 2021 | 21.5× | 16.6× | 22.4× |
| 2020 | 16.6× | 13.9× | 20.9× |
| 2019 | 20.9× | 19.9× | 26.2× |
| 2018 | 22.3× | 18.7× | 30.7× |
| 2017 | 19.2× | 17.5× | 46.1× |
| 2016 | 43.1× | 23.4× | 99.6× |
| 2015 | 29.5× | 23.1× | 33.4× |
| 2014 | 30.1× | 21.0× | 37.9× |
| 2013 | 34.1× | 29.2× | 50.2× |
| 2012 | 35.2× | 35.1× | 50.8× |
Against its peers
Companies in Software - Application nearest Healthstream's size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| HSTMHealthstream | 14.7× |
| UPWKUpwork | 5.8× |
| LZLegalzoom.Com | 8.0× |
| GDRXGoodRx | 6.1× |
| EVEREverQuote | 8.4× |
| TASKTaskUs | 6.5× |
| YEXTYext | 13.7× |
| MNTNMNTN | n/m |
| NRDSNerdwallet | 4.3× |
| IBEXIBEX | 20.1× |
| CARSCars.com | 3.9× |
| Peer median | 6.5× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on Healthstream
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.